tryptophan and Ambulation Disorders, Neurologic

tryptophan has been researched along with Ambulation Disorders, Neurologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bini, V; Bortolato, M; Carta, M; Collu, M; Fadda, F; Frau, R; Stancampiano, R1

Other Studies

1 other study(ies) available for tryptophan and Ambulation Disorders, Neurologic

ArticleYear
Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HTâ‚‚ receptor activation.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:10

    Topics: Acoustic Stimulation; Animals; Behavior, Animal; Brain; Dyskinesia, Drug-Induced; Gait Disorders, Neurologic; Male; Nerve Tissue Proteins; Neural Inhibition; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Reflex, Startle; Sensory Gating; Serotonergic Neurons; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Tryptophan

2013